Squarepoint Ops LLC Graphite Bio, Inc. Transaction History

Squarepoint Ops LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$2.24 - $2.66 $27,704 - $32,898	12,368 New	12,368 $32,000
Q1 2023 May 15, 2023	BUY	$1.85 - $3.21 $26,109 - $45,302	14,113 New	14,113 $34,000
Q2 2022 Aug 15, 2022	BUY	$2.14 - $5.23 $25,142 - $61,447	11,749 New	11,749 $32,000
Q3 2021 Nov 15, 2021	SELL	$15.81 - $28.39 $632,400 - $1.14 Million	-40,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$18.5 - $30.73 $740,000 - $1.23 Million	40,000 New	40,000 $1.23 Million

637K

Ticker GRPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,211,200
Description
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.